How to Buy Colgate Palmolive Co Stock
Colgate Palmolive Co
Colgate Palmolive Co is a household & personal product company located in New York, United States, which is part of the Consumer Defensive sector, and is traded under the ticker CL on the NYSE exchange.
Colgate Palmolive Co stock last closed at $88.84, up 1.01% from the previous day, and has decreased 1.86% in one year. It has overperformed other stocks in the Household & Personal Products industry by 0.34 percentage points. Colgate Palmolive Co stock is currently +19.18% from its 52-week low of $74.55, and -10.56% from its 52-week high of $99.33.
There are currently 801.55M CL shares outstanding. The market value of CL is $71.21B. In the past 24 hours, 5.71M CL shares were traded.
How to Buy Colgate Palmolive Co Stock
Not sure how to invest in Colgate Palmolive Co stock? Here's how.
- Choose where to buy Colgate Palmolive Co stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Colgate Palmolive Co stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Pick your method of payment and add your information.
- Research Colgate Palmolive Co stock: The Colgate Palmolive Co ticker symbol is CL. Is Colgate Palmolive Co stock a good investment? Should you buy shares of CL? How do CL's underlying business fundamentals look? Do top analysts think Colgate Palmolive Co is a good buy? Why has CL's stock price moved recently? (Hint: Our stock analysis website can help you understand if CL is a good stock to buy).
- Make your CL purchase: Decide if you will purchase CL shares at the current market price or use a limit order to purchase CL stock at a specific price.
- Keep tabs on your investment in CL: Create a watchlist to get the latest news on your new investment in Colgate Palmolive Co shares.
Step 1: Choose where to buy Colgate Palmolive Co stock
You will need an online brokerage account to access the NYSE market and buy CL shares.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal information so you can invest in CL stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open a new brokerage account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have filled out your info on the best beginner stock app, you need to deposit funds:
Check out the walkthrough below if you need help depositing money into your new investment account.
Step 4: Research Colgate Palmolive Co stock
After you have chosen the best place to buy Colgate Palmolive Co stock, it's absolutely critical to research their stock prior to buying, so you can comprehend the risk as well as the opportunity.
Colgate Palmolive Co Numbers
CL Due Diligence Score
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on CL's stock page.
How is CL stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge CL's true value.
Using relative valuations methods:
- CL may be overvalued based on its P/E ratio of 33.65x, relative to Household & Personal Products industry P/E ratio of 12.43x
- CL may be overvalued based on its P/B ratio of 1,318.69x, relative to Household & Personal Products industry P/B ratio of 6.76x
- CL may be overvalued based on its PEG ratio of 1.68x
You can access additional valuation research on CL's stock here.
CL Financial Health Summary
Positive Financial Indicators:
- CL earnings of $3.20B is not sufficient to cover its interest payments.
- CL's operating cash flow of $4.20B allows it to safely service it's debt of $7.99B.
Negative Financial Indicators:
- CL has a relatively high debt to equity ratio of 295.65.
- CL profit margin has gone down from 14.4% to 10.5% in the past year.
- There are more long-term liabilities than short-term assets on the CL balance sheet.
- There are more short-term liabilities than short-term assets on the CL balance sheet.
- Total CL debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy CL stock
Out of 15 sell side analysts who give forecasts on CL, the consensus analyst rating on CL is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent CL Analyst Recommendations
Robert Ottenstein, a bottom 11% analyst from Evercore ISI Group maintains CL with a buy rating and raises their CL price target from $94.00 to $100.00, on Feb 2, 2026.
Michael Lavery, a top 13% analyst from Piper Sandler maintains CL with a strong buy rating and raises their CL price target from $88.00 to $96.00, on Feb 2, 2026.
Bryan Spillane, a top 43% analyst from Bank of America maintains CL with a strong buy rating and raises their CL price target from $90.00 to $100.00, on Feb 2, 2026.
Dara Mohsenian, a top 6% analyst from Morgan Stanley maintains CL with a strong buy rating and raises their CL price target from $87.00 to $100.00, on Feb 2, 2026.
Morgan Stanley's Dara Mohsenian raised their price target on Colgate Palmolive Co (NYSE: CL) by 14.9% from $87 to $100 on 2026/02/02. The analyst maintained their Strong Buy rating on the stock.
Colgate-Palmolive reported its Q4 and FY 2025 earnings.
Raising their price target, Mohsenian highlighted the quarter's "solid" EPS beat.
That beat Q/Q sequential organic sales growth recovery affirm Q3 2025 was a trough for Colgate-Palmolive, the analsyt noted.
Looking ahead, Mohsenian called management's FY 2026 guidance "conservative."
Earnings Report
Colgate-Palmolive reported:
For Q4:
- EPS of $0.95, which beat both the Zacks Consensus Estimate and Q4 2024, both $0.91.
- Revenue of $5.23B, which beat the Zacks Consensus Estimate by 2.79% and Q4 2024's $4.94B.
For FY 2025:
- EPS of $3.69, up from FY 2024's $3.60.
- Revenue of $20.38B, up from FY 2024's $20.1B.
For FY 2026, management guided:
- 2% to 6% Y/Y revenue growth, including a low-single-digit positive impact from foreign exchange.
President & CEO Noel Wallace commented: “We are pleased to have exited 2025 with accelerated growth momentum on both the top and bottom lines, even in the face of sluggish category growth in many markets.
"Net sales and organic sales grew in every category during the quarter, led by strength in oral care and pet nutrition, excluding private label.
"Our 2025 performance highlights the resilience of our business model and the strength of our brands.
"Through the successful execution of our 2025 strategy, we have grown our company significantly over the last five years despite many challenges.
"Our new 2030 strategy builds on that success.
"We have laid out a clear path to accelerate our growth going forward with a focus on leveraging the global reach and penetration of our brands, building the incremental benefit of superior, science-based innovation, harnessing the power of best-in-class omni-channel demand generation, leading in capabilities like data, analytics and AI and evolving our high-impact, inclusive culture.
"As we begin 2026, while we expect the difficult operating environment and slower category growth to continue in the short term, we are operating from a position of strength and are confident that the changes we are making will enable us to deliver consistent, compounded earnings per share growth and drive shareholder value in the long term.”
Steve Powers, a top 17% analyst from Deutsche Bank maintains CL with a hold rating and raises their CL price target from $83.00 to $90.00, on Feb 2, 2026.
You can dive deeper into what analysts are forecasting on the Colgate Palmolive Co stock forecast page.
CL Technical Indicators
CL Revenue
Last year, CL earnings were $2.13B. During the past five year, CL's earnings have grown by -3.47% per year. This was slower than the Household & Personal Products industry average of 4.56%.
Last year, CL revenue was $20.38B. In the last five year, CL's revenue has increased by 4.35% per year. This was faster than the Household & Personal Products industry average of 2.66%.
Dig into CL's earnings and revenue performance here.
Latest Insiders Trades at CL
Over the last year, insiders at CL have sold more shares than they have bought.
Jennifer Daniels, CLO and Secretary of CL, was the latest CL insider to sell. They sold $1,199,282.10 worth of CL shares on Feb 23, 2026.
Research more about who owns CL shares here.
Does CL stock generate passive income?
Colgate Palmolive Co pays a dividend of 2.34%, compared to the Household & Personal Products industry's average dividend yield of 3.34%. If you owned $1,000 of CL stock, you would have received $23.41 last year.
Colgate Palmolive Co dividend payments have consistently grown over the past decade and have remained stable.
Find more analysis about Colgate Palmolive Co dividend yield and history here.
What others are saying about CL
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your CL purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly fine. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at an exact price limit, use a limit order.
Press the Open button and eToro will execute your order.
If you want more assistance buying stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your investment in CL
Now that you own some shares in CL, you'll want to keep up with your new shares.
Create a watchlist to track the latest developments regarding your CL stock.
CL Feed
How to Buy Stock in Colgate Palmolive Co
To summarize, here are the 6 steps you need to take to buy Colgate Palmolive Co stock right now:
- Choose where to buy Colgate Palmolive Co stock
- Open a brokerage account
- Deposit money your investment account
- Research Colgate Palmolive Co stock
- Make your CL purchase
- Keep tabs on your investment in CL
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Colgate Palmolive Co, create a watchlist today.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.